Confirmed false positive proteinuria in patients with systemic lupus erythematosus taking hydroxychloroquine: A spot sample measurement

Clinical Laboratory

Volumn 61, Issue 5-6, 2015, Pages 581-586

  Wang, Jiunn Min ^a,b   Li, Jen Ying ^a   Huang, Wei Chang ^a,b   Wen, Chih Yu ^c   Lee, Ching Hsiao ^b   Yang, Chin Yao ^d   Wu, Ming Feng ^a,e  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHENG CHING GENERAL HOSPITAL   (Taiwan)

^e CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Dipstick; False positive; Geniquin; Odds ratio; Plaquenil

Indexed keywords

ANTIRHEUMATIC AGENT; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; AGED; CHEMICALLY INDUCED; CHILD; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEINURIA; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; CHILD; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEINURIA; YOUNG ADULT;

EID: 84934293142     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2014.140706     Document Type: Article

References (33)

1. Freire EAM, Souto LM, Ciconelli RM. Assessment measures in systemic lupus erythematosus. Rev Bras Reumatol 2011;51:70-80.
2. Lam GKW, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005;23(Suppl 39):S120-32.
3. Bertoli AM, Alarcon GS. Epidemiology of Systemic Lupus Erythematosus. In: Systemic Lupus Erythematosus: A Companion to Rheumatology, Tsokos GC, Gordon C, Smolen J, eds, 1st ed. Mosby, 2007:1-18.
4. Hopkinson N. Epidemiology of systemic lupus erythematosus. Ann Rheum Dis 1992;51:1292-4.
5. Tucker LB, Menon S, Schaller J.F., Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
6. Petri M. Hopkins lupus cohort, 1999 update. Rheum Dis Clin North Am 2000;26:199-213.
7. Cervera R, Khamashta M, Font J., et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 1993;72:113-24.
8. Lahit RG. Non-steroid Treatment of Systemic Lupus Erythematosus. In: Systemic Lupus Erythematosus: A Companion to Rheumatology, Tsokos GC, Gordon C, Smolen J, eds, 1 st ed. Mosby, 2007:483-97.
9. Christian MT, Watson AR. The investigation of proteinuria. Curr Paediatrics 2004;14:547-55.
10. Wilson LA. Urinalysis. Nurs Stand 2005; 19:51-4.
11. Kashif W, Siddiqi N, Dincer A.P., Dincer HE, Hirsch S. Proteinuria: How to evaluate an important finding. Cleve Clin J Med 2003;70:535-47.
12. da Silva A.S., Falkenberg M. Analytical interferences of drugs in the chemical examination of urinary protein. Clinical Biochemistry 2007;40:1074-6.
13. da Silva A.S., Falkenberg M. Analytical interference of quinolone antibiotics and quinine derived drugs on urinary protein determined by reagent strips and the pyrogallol red-molybdate protein assay. Clinical Biochemistry 2011;44:1000-4.
14. Luxton RW, Patel P, Keir G., Thompson EJ. A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in micro-titer plate wells. Clin Chem 1989;35: 1731-4.
15. Tan EM, Cohen AS, Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
17. Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry 2010;19:227-9.
18. Norušis MJ. Non-parametric tests. In: PASW statistics 18: guide to data analysis. Prentice Hall 2010:385-412.
19. Jhang JS, Sireci AN, Kratz A. Post-analysis: medical decision making. In: Henry's clinical diagnosis and management by laboratory methods, McPherson RA, Pincus MR, eds, 22nd ed. Elsevier Saunders, Philadelphia 2011:80-90.
20. Gladman DD, Goldsmith CH, Urowitz M.B., et al. Cross-cultural validation and reliability of three disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
21. Liang HL, Socher SA, Larson M.A., Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32: 1107-18.
22. Hay EM, Bacon PA, Gordon C, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in SLE. Q J Med 1993;86:447-58.
23. Gladman DD, Ibafiez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
24. Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician 2000;62:1333-40.
25. Ruiz-Irastorza G., Khamashta MA, Gordon C, et al. Measuring Systemic Lupus Erythematosus Activity During Pregnancy: Validation of the Lupus Activity Index in Pregnancy Scale. Arthritis Rheumatism 2004;51:78-82.
26. Clowse MEB, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in Lupus. Obstet Gynecol 2006;107:293-9.
27. Batlle-Gualda E., Martinez AC, Guerra R.A., Pascual E. Urinary albumin excretion in patients with systemic lupus erythematosus without renal disease. Annals of the Rheumatic Diseases 1997; 56:386-9.
28. Valente de Almeida R, Rocha de Carvalho JG, de Azevedo VF, et al. Microalbuminuria and renal morphology in the evaluation of subclinical lupus nephritis. Clin Nephrol 1999;52:218-29.
29. Hydroxychloroquine (Systemic), Available at: http://www.drugs.com/mmx/plaquenil.html. accessed I June 2013.
30. Hydroxychloroquine: Drug information, Available at: http://www.uptodaOte.com/online/content.Accessed 1 June 2013.
31. ARKRAY Aution Stick 10EA package insert.
32. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst 2008; 100:988-95.
33. Lafata JE, Simpkins J, Lamerato L., Poisson L, Divine G, Johnson CC. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 2004;13:2126-32.